Z-1457-2017 Class II Terminated

Recalled by Merge Healthcare, Inc. — Hartland, WI

FDA device recall Z-1457-2017 was initiated by Merge Healthcare, Inc. on Apr 4, 2016 and is designated Class II. Reason for recall: In some instances, the system will lock tabs within a study, even when a second user does not have the study open on a different workstation. The recall status is terminated (terminated Aug 5, 2019). Affected quantity: 361 sites potentially have the affected versions.

Recall details

Product Type
Devices
Report Date
Mar 22, 2017
Initiation Date
Apr 4, 2016
Termination Date
Aug 5, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
361 sites potentially have the affected versions

Product description

Merge Hemo software. Product Usage: Merge Hemo is a hemodynamic monitoring system that records and displays physiological data.

Reason for recall

In some instances, the system will lock tabs within a study, even when a second user does not have the study open on a different workstation.

Distribution pattern

US Nationwide Distribution.

Code information

Versions 6.10, 6.10.1, 6.10.2, 6.10.3, 7.10, 7.20, 7.20.1, 8.10.0, 8.20, 9.10.0, 9.20, 9.20.2, 9.20.3, 9.30, 9.40, 9.40.1, 9.40.2, and 9.40.3

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1457-2017
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1457-2017. Report a data issue: hello@regdatalab.com.